Secukinumab B
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
Product Specifications
CAS Number
1229022-83-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6281355-01 0.2 mL
CCD33, CT (CCDC33, Coiled-coil domain-containing protein 33, Cancer/testis antigen 61) (APC)
Ask
View Details MBS6281355-02 5x 0.2 mL
CCD33, CT (CCDC33, Coiled-coil domain-containing protein 33, Cancer/testis antigen 61) (APC)
Ask
View Details